Patient Services Survey 2016: Pharma’s Growing Opportunity - Accenture | Pharmaguy's Insights Into Drug Industry News | Scoop.it
We surveyed 200+ patient services executives in the pharma industry to understand where their companies are in developing patient services
The future of patient services is bright.

Patient Services offˆers pharmaceutical companies a tremendous opportunity—for those willing to invest in the right places and let patients know about them in the right way. We surveyed 200+ patient services executives in the pharma industry to understand where their companies are in developing patient services and where they intend to go over the next two years and contrasts that with patients told us they want, value and expect from patient services.

Our survey covered seven therapeutic areas: heart, lungs, brain, immune systems, bones, hormone/metabolism, and cancer. And guess what? Our study revealed that the future of patient services is bright—for both pharmaceutical companies and patients.

KEY FINDINGS:

  1. Patient Services are delivering value with a significant increase in focus and investment expected over the next two years.
  2. Companies are going big with investments in digital engagement technologies and supporting analytics.
  3. Much of this investment (but not all) is aligned to what patients value

POTENTIAL BENEFITS:

  1. Companies primarily make patients aware of their services through healthcare professionals, however, less than 1 in 5 patients are aware of the services.
  2. The majority of companies are not able to precisely measure the impact of patient services on outcomes.
  3. Heads of patient services/experience are rapidly emerging but without full ownership of the patient experience.

This research report is intended to help pharmaceutical companies’ hone in on the services that present the highest potential—for them and the people who use their therapeutics—so they can take a leadership role in shaping this rapidly evolving market and prepare for the shift from delivering products to delivering better patient and health system outcomes.


Via rob halkes